[HTML][HTML] MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis
N Datta, C Johnson, D Kao, P Gurnani… - Pharmacological …, 2023 - Elsevier
An emerging but less explored shared pathophysiology across microbiota-gut-brain axis
disorders is aberrant miRNA expression, which may represent novel therapeutic targets …
disorders is aberrant miRNA expression, which may represent novel therapeutic targets …